BMRN
$81.02
Biomarin Pharmaceut
($1.97)
(2.37%)

Earnings History

Earnings
Revenue
Reaction
Drift
Revenue Below Estimates
FY 2012
2/16/2012
4:00:21 PM
-4.0%
-2.4%
Guidance:
Consensus:
BioMarin Pharmaceutical Sees Revenue Below Estimates

BioMarin Pharmaceutical, Inc. said it expects 2012 revenue of $465.0 million to $510.0 million. The current consensus estimate is revenue of $512.0 million for the year ending December 31, 2012.
Reaffirms
FY 2012
10/25/2012
4:00:16 PM
$475.0 mil to $510.0 mil
$496.4 mil
1.8%
-6.1%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2012 revenue of $475.0 million to $510.0 million. The current consensus estimate is revenue of $496.4 million for the year ending December 31, 2012.
Revenue Below Estimates
FY 2013
2/21/2013
4:03:05 PM
5.3%
11.7%
Guidance:
Consensus:
BioMarin Pharmaceutical Sees Revenue Below Estimates

BioMarin Pharmaceutical, Inc. said it expects 2013 revenue of $530.0 million to $555.0 million. The current consensus estimate is revenue of $563.3 million for the year ending December 31, 2013.
Reaffirms
FY 2013
4/25/2013
4:03:42 PM
$530.0 mil to $555.0 mil
$551.2 mil
0.5%
7.4%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2013 revenue of $530.0 million to $555.0 million. The current consensus estimate is revenue of $551.2 million for the year ending December 31, 2013.
Reaffirms
FY 2013
7/25/2013
4:00:09 PM
$530.0 mil to $555.0 mil
$544.7 mil
0.1%
2.4%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2013 revenue of $530.0 million to $555.0 million. The current consensus estimate is revenue of $544.7 million for the year ending December 31, 2013.
Reaffirms
FY 2013
10/24/2013
5:33:36 PM
$530.0 mil to $555.0 mil
$550.9 mil
-3.9%
-7.8%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2013 revenue of $530.0 million to $555.0 million. The current consensus estimate is revenue of $550.9 million for the year ending December 31, 2013.
In-line Guidance
FY 2014
2/26/2014
4:09:12 PM
0.9%
-6.2%
Guidance:
Consensus:
BioMarin Pharmaceutical Guides In-line

BioMarin Pharmaceutical, Inc. said it expects 2014 revenue of $650.0 million to $680.0 million. The current consensus estimate is revenue of $669.0 million for the year ending December 31, 2014.
Reaffirms
FY 2014
5/1/2014
4:11:46 PM
$650.0 mil to $680.0 mil
$674.7 mil
-4.3%
0.9%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2014 revenue of $650.0 million to $680.0 million. The current consensus estimate is revenue of $674.7 million for the year ending December 31, 2014
Revenue Above Estimates
FY 2014
7/30/2014
4:01:14 PM
$745.0 mil to $765.0 mil
$676.0 mil
1.2%
-1.8%
Guidance:
Consensus:
BioMarin Pharmaceutical Raises Revenue Guidance

BioMarin Pharmaceutical, Inc. said it now expects 2014 revenue of $745.0 million to $765.0 million. The company's previous guidance was revenue of $650.0 million to $680.0 million current consensus estimate is revenue of $676.0 million for the year ending December 31, 2014.
Revenue Below Estimates
FY 2015
2/25/2015
4:01:11 PM
1.2%
4.8%
Guidance:
Consensus:
BioMarin Pharmaceutical Sees Revenue Below Estimates

BioMarin Pharmaceutical, Inc. said it expects 2015 revenue of $840.0 million to $870.0 million. The current consensus estimate is revenue of $880.6 million for the year ending December 31, 2015.
Raises Guidance In-line with Estimates
FY 2015
4/30/2015
4:01:18 PM
$850.0 mil to $880.0 mil
$870.4 mil
3.5%
5.9%
Guidance:
Consensus:
BioMarin Raises Guidance to be In-lien with Estimates

BioMarin Pharmaceutical, Inc. said it expects 2015 revenue of $850.0 million to $880.0 million. The company's previous guidance was revenue of $840.0 million to $870.0 million and the current consensus estimate is revenue of $870.4 million for the year ending December 31, 2015.
Reaffirms Below Estimates
FY 2015
8/3/2015
4:02:10 PM
$850.0 mil to $880.0 mil
$881.6 mil
-2.3%
-6.2%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms Below Estimates

BioMarin Pharmaceutical, Inc. said it continues to expect 2015 revenue of $850.0 million to $880.0 million. The current consensus estimate is revenue of $881.6 million for the year ending December 31, 2015.
Revenue Below Estimates
FY 2015
10/29/2015
4:03:14 PM
$880.0 mil to $900.0 mil
$897.4 mil
2.8%
2.9%
Guidance:
Consensus:
BioMarin Pharmaceutical Lowers Guidance

BioMarin Pharmaceutical, Inc. said it expects 2015 revenue of $880.0 million to $900.0 million. The company's previous guidance was revenue of $850.0 million to $880.0 million and the current consensus estimate is revenue of $897.4 million for the year ending December 31, 2015.
Revenue Below Estimates
FY 2016
2/25/2016
4:04:26 PM
4.9%
13.1%
Guidance:
Consensus:
BioMarin Pharmaceutical Sees Revenue Below Estimates

BioMarin Pharmaceutical, Inc. said it expects 2016 revenue of $1.05 billion to $1.10 billion. The current consensus estimate is revenue of $1.15 billion for the year ending December 31, 2016.
Reaffirms
FY 2016
4/28/2016
4:02:05 PM
$1.05 bil to $1.10 bil
$1.09 bil
-0.5%
-3.2%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2016 revenue of $1.05 billion to $1.10 billion. The current consensus estimate is revenue of $1.09 billion for the year ending December 31, 2016.
Revenue Above Estimates
FY 2016
8/4/2016
4:04:57 PM
$1.10 bil to $1.15 bil
$1.09 bil
-0.7%
-8.4%
Guidance:
Consensus:
BioMarin Pharmaceutical Raises Guidance

BioMarin Pharmaceutical, Inc. said it expects 2016 revenue of $1.10 billion to $1.15 billion. The company's previous guidance was revenue of $1.05 billion to $1.10 billion and the current consensus estimate is revenue of $1.09 billion for the year ending December 31, 2016.
Reaffirms
FY 2016
10/27/2016
4:08:34 PM
0.1%
2.8%
Guidance:
Consensus:
BioMarin Pharmaceutical Reaffirms

BioMarin Pharmaceutical, Inc. said it continues to expect 2016 revenue of $1.10 billion to $1.15 billion. The current consensus estimate is revenue of $1.13 billion for the year ending December 31, 2016.
Date
Grade
Actual
Earnings
Whisper
Consensus
Estimate
Surprise
Growth
Gap
Drift
2/16/2012
4:00:21 PM
Dec '11
Q4 '11
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G F
EPS
Rev
($0.23)
$107.85 Mil
-
($0.11)
$116.30 Mil
-109.1%
-7.3%
-
6.1%
-4.9%
-2.4%
4/26/2012
4:00:18 PM
Mar '12
Q1 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.21)
$116.65 Mil
-
($0.14)
$118.79 Mil
-50.0%
-1.8%
-
6.6%
-1.8%
3.3%
8/1/2012
4:00:14 PM
Jun '12
Q2 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.27)
$124.02 Mil
-
($0.20)
$121.69 Mil
-35.0%
1.9%
-
12.1%
1.1%
-1.1%
10/25/2012
4:00:16 PM
Sep '12
Q3 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.04)
$128.12 Mil
($0.25)
($0.21)
$127.25 Mil
84.0%
0.7%
-
13.0%
4.4%
-6.1%
2/21/2013
4:03:05 PM
Dec '12
Q4 '12
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.43)
$131.94 Mil
-
($0.27)
$129.90 Mil
-59.3%
1.6%
-
22.3%
0.2%
11.7%
4/25/2013
4:03:42 PM
Mar '13
Q1 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.31)
$127.93 Mil
-
($0.28)
$131.45 Mil
-10.7%
-2.7%
-
9.7%
-1.2%
7.4%
7/25/2013
4:00:09 PM
Jun '13
Q2 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.16)
$136.81 Mil
-
($0.28)
$134.11 Mil
42.9%
2.0%
-
10.3%
-1.3%
2.4%
10/24/2013
5:33:36 PM
Sep '13
Q3 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.38)
$136.87 Mil
-
($0.28)
$140.03 Mil
-35.7%
-2.3%
-
6.8%
-2.0%
-7.8%
2/26/2014
4:09:12 PM
Dec '13
Q4 '13
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.27)
$146.87 Mil
-
($0.34)
$143.27 Mil
20.6%
2.5%
-
11.3%
-0.3%
-6.2%
5/1/2014
4:11:46 PM
Mar '14
Q1 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.27)
$151.55 Mil
-
($0.50)
$145.86 Mil
46.0%
3.9%
-
18.5%
-3.8%
0.9%
7/30/2014
4:01:14 PM
Jun '14
Q2 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.19)
$191.79 Mil
-
($0.42)
$159.57 Mil
54.8%
20.2%
-
40.2%
6.1%
-1.8%
10/23/2014
4:02:16 PM
Sep '14
Q3 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.16)
$176.85 Mil
-
($0.22)
$206.02 Mil
27.3%
-14.2%
-
29.2%
0.5%
9.4%
2/25/2015
4:01:11 PM
Dec '14
Q4 '14
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.30)
$230.85 Mil
-
($0.59)
$189.50 Mil
49.2%
21.8%
-
57.2%
0.7%
4.8%
4/30/2015
4:01:18 PM
Mar '15
Q1 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.25)
$203.26 Mil
-
($0.53)
$202.71 Mil
52.8%
0.3%
-
34.1%
2.5%
5.9%
8/3/2015
4:02:10 PM
Jun '15
Q2 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.22)
$250.52 Mil
($0.47)
($0.53)
$218.16 Mil
53.2%
14.8%
-
30.6%
-1.5%
-6.2%
10/29/2015
4:03:14 PM
Sep '15
Q3 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.60)
$208.90 Mil
-
($0.66)
$216.32 Mil
9.1%
-3.4%
-
18.1%
-1.9%
2.9%
2/25/2016
4:04:26 PM
Dec '15
Q4 '15
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.58)
$227.94 Mil
-
$1.03
$224.38 Mil
-156.3%
1.6%
-
-1.3%
0.3%
13.1%
4/28/2016
4:02:05 PM
Mar '16
Q1 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.35)
$236.74 Mil
-
($0.85)
$241.03 Mil
58.8%
-1.8%
-
16.5%
-2.0%
-3.2%
8/4/2016
4:04:57 PM
Jun '16
Q2 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.11)
$300.13 Mil
-
($0.50)
$280.45 Mil
78.0%
7.0%
-
19.8%
1.3%
-8.4%
10/27/2016
4:08:34 PM
Sep '16
Q3 '16
Earnings Whisper GradeE a rn in gs Wh is pe r® ed ar G -
EPS
Rev
($0.13)
$279.90 Mil
-
($0.39)
-
66.7%
-
-
34.0%
-1.6%
2.8%
EPS
Rev
-
-
-
($0.40)
-
-
-
-
-
EPS
Rev
-
-
-
($0.37)
-
-
-
-
-
2/17/2011
$28.29
($0.02)
$376.3 Mil
-
-
-
2/16/2012
$37.70
($0.48)
$441.4 Mil
-
17.3%
33.3%
2/21/2013
$53.27
($0.95)
$500.7 Mil
-
13.4%
41.3%
2/26/2014
$82.56
($0.76)
$548.5 Mil
-
9.5%
55.0%
2/25/2015
$107.50
($0.77)
$751.0 Mil
-
36.9%
30.2%
2/25/2016
$76.41
($1.58)
$889.9 Mil
-
18.5%
-28.9%
2/25/2017
$81.02
($0.11)
-
-
-
6.0%
2/25/2018
$40.23
($0.91)
-
-
-
-50.4%
2/25/2019
-
$0.03
-
-
-
-

Price Projection

Current Value
-
-
Projected Price
$40
-50%